Propoxyphene for Maintenance Treatment of Narcotic Addiction

George E. Woody; Jim Mintz; Forest Tennant; Charles P. O'brien; A. Thomas McLellan; Martin Marcovici

doi:10.1001/archpsyc.1981.01780330056005

Propoxyphene for Maintenance Treatment of Narcotic Addiction

George E. Woody, Jim Mintz, Forest Tennant, Charles P. O'brien, A. Thomas McLellan, Martin Marcovici

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Two studies compared propoxyphene napsylate (Darvon-N) with methadone hydrochloride as maintenance treatment for narcotic addicts. Most measures indicated that methadone was more effective than propoxyphene as a maintenance drug. Patients receiving propoxyphene reported more withdrawalrelated symptoms early in treatment, tended to drop out sooner than patients receiving methadone, and were more likely to abuse heroin. Nevertheless, follow-up interviews at one and six months after treatment indicated no between-group differences in adjustment.

Original language	English (US)
Pages (from-to)	898-900
Number of pages	3
Journal	Archives of General Psychiatry
Volume	38
Issue number	8
DOIs	https://doi.org/10.1001/archpsyc.1981.01780330056005
State	Published - Aug 1981
Externally published	Yes

ASJC Scopus subject areas

Arts and Humanities (miscellaneous)
Psychiatry and Mental health

Access to Document

10.1001/archpsyc.1981.01780330056005

Fingerprint Dive into the research topics of 'Propoxyphene for Maintenance Treatment of Narcotic Addiction'. Together they form a unique fingerprint.

Cite this

@article{0b0f476b70324f898c6d54fa1e6818ed,

title = "Propoxyphene for Maintenance Treatment of Narcotic Addiction",

abstract = "Two studies compared propoxyphene napsylate (Darvon-N) with methadone hydrochloride as maintenance treatment for narcotic addicts. Most measures indicated that methadone was more effective than propoxyphene as a maintenance drug. Patients receiving propoxyphene reported more withdrawalrelated symptoms early in treatment, tended to drop out sooner than patients receiving methadone, and were more likely to abuse heroin. Nevertheless, follow-up interviews at one and six months after treatment indicated no between-group differences in adjustment.",

author = "Woody, {George E.} and Jim Mintz and Forest Tennant and O'brien, {Charles P.} and McLellan, {A. Thomas} and Martin Marcovici",

year = "1981",

month = aug,

doi = "10.1001/archpsyc.1981.01780330056005",

language = "English (US)",

volume = "38",

pages = "898--900",

journal = "JAMA Psychiatry",

issn = "2168-622X",

publisher = "American Medical Association",

number = "8",

}

TY - JOUR

T1 - Propoxyphene for Maintenance Treatment of Narcotic Addiction

AU - Woody, George E.

AU - Mintz, Jim

AU - Tennant, Forest

AU - O'brien, Charles P.

AU - McLellan, A. Thomas

AU - Marcovici, Martin

PY - 1981/8

Y1 - 1981/8

N2 - Two studies compared propoxyphene napsylate (Darvon-N) with methadone hydrochloride as maintenance treatment for narcotic addicts. Most measures indicated that methadone was more effective than propoxyphene as a maintenance drug. Patients receiving propoxyphene reported more withdrawalrelated symptoms early in treatment, tended to drop out sooner than patients receiving methadone, and were more likely to abuse heroin. Nevertheless, follow-up interviews at one and six months after treatment indicated no between-group differences in adjustment.

AB - Two studies compared propoxyphene napsylate (Darvon-N) with methadone hydrochloride as maintenance treatment for narcotic addicts. Most measures indicated that methadone was more effective than propoxyphene as a maintenance drug. Patients receiving propoxyphene reported more withdrawalrelated symptoms early in treatment, tended to drop out sooner than patients receiving methadone, and were more likely to abuse heroin. Nevertheless, follow-up interviews at one and six months after treatment indicated no between-group differences in adjustment.

UR - http://www.scopus.com/inward/record.url?scp=0019390268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019390268&partnerID=8YFLogxK

U2 - 10.1001/archpsyc.1981.01780330056005

DO - 10.1001/archpsyc.1981.01780330056005

M3 - Article

C2 - 6114721

AN - SCOPUS:0019390268

VL - 38

SP - 898

EP - 900

JO - JAMA Psychiatry

JF - JAMA Psychiatry

SN - 2168-622X

IS - 8

ER -